Cargando…
Formulation of a killed whole cell pneumococcus vaccine - effect of aluminum adjuvants on the antibody and IL-17 response
BACKGROUND: Streptococcus pneumoniae causes widespread morbidity and mortality. Current vaccines contain free polysaccharides or protein-polysaccharide conjugates, and do not induce protection against serotypes that are not included in the vaccines. An affordable and broadly protective vaccine is ve...
Autores principales: | HogenEsch, Harm, Dunham, Anisa, Hansen, Bethany, Anderson, Kathleen, Maisonneuve, Jean-Francois, Hem, Stanley L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161839/ https://www.ncbi.nlm.nih.gov/pubmed/21801401 http://dx.doi.org/10.1186/1476-8518-9-5 |
Ejemplares similares
-
Mechanism of Immunopotentiation and Safety of Aluminum Adjuvants
por: HogenEsch, Harm
Publicado: (2013) -
Aluminum Adjuvants—‘Back to the Future’
por: Laera, Donatello, et al.
Publicado: (2023) -
Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want
por: HogenEsch, Harm, et al.
Publicado: (2018) -
Mechanism of activation of porcine dendritic cells by an α-D-glucan nanoparticle adjuvant and a nanoparticle/poly(I:C) combination adjuvant
por: Hernandez-Franco, Juan F., et al.
Publicado: (2022) -
Alpha-D-glucan-based vaccine adjuvants: Current status and future perspectives
por: Patil, Veerupaxagouda, et al.
Publicado: (2022)